Toyota A, Goto M, Miyamoto M, Nagashima Y, et al. Novel protein kinase cAMP-Activated Catalytic Subunit Alpha (PRKACA) inhibitor shows anti-tumor activity in a fibrolamellar hepatocellular carcinoma model. Biochem Biophys Res Commun 2022;621:157-161.
PMID: 35839742